VIKING GLOBAL INVESTORS LP

Average Profitability
11.32%
Insider Buys Quantity
15
Insider Buys Sum
$343.84M
Insider Sells Quantity
9
Insider Sells Sum
$544.72M

Insider Activity of VIKING GLOBAL INVESTORS LP

According to the SEC Form 4 filings, VIKING GLOBAL INVESTORS LP, being in a position of

  1. 10 percent owner at 4D Molecular Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 540000 shares for $10.55M,
    over all time since 2020-12-15, has bought 3050000 shares for $64.2M, and sold 540000 shares for $10.55M.

The largest purchase of all time was on 2019-06-27 and amounted to 9411800 shares of BridgeBio Pharma, Inc. for $160M.

The largest sale of all time was on 2024-01-02 and amounted to 6500000 shares of APi Group Corporation for $203.45M.

Biography of VIKING GLOBAL INVESTORS LP

No biography is available at this moment.

2024-06-17SaleAPi Group Corporation
APG
10 percent owner
39,032
0.0143%
$38.15$1.49M-10.23%
2024-03-05SaleAPi Group Corporation
APG
10 percent owner
3.04M
1.0979%
$34.25$104.07M-3.42%
2024-01-04Sale4D Molecular Therapeutics, Inc.
FDMT
10 percent owner
540,000
1.2278%
$19.53$10.55M+15.27%
2024-01-02SaleAPi Group Corporation
APG
10 percent owner
6.5M
2.6232%
$31.30$203.45M+8.25%
2023-08-28PurchaseInhibrx, Inc.
INBX
10 percent owner
511,627
1.13%
$19.35$9.9M+32.3%
2023-07-18SaleBridgeBio Pharma, Inc.
BBIO
10 percent owner
1.5M
1.0576%
$35.00$52.5M-10.82%
2023-06-22SaleRoivant Sciences Ltd.
ROIV
10 percent owner
13M
1.8097%
$9.90$128.7M+8.43%
2023-05-09Purchase4D Molecular Therapeutics, Inc.
FDMT
10 percent owner
850,000
2.3982%
$16.00$13.6M+4.5%
2021-09-17PurchasePROCEPT BioRobotics Corporation
PRCT
10 percent owner
400,000
3.0225%
$35.00$14M-10.97%
2021-09-03SaleFIGS, Inc.
FIGS
10 percent owner
84,826
0.0531%
$44.92$3.81M-54.58%
2021-09-02SaleFIGS, Inc.
FIGS
10 percent owner
315,174
0.2036%
$47.28$14.9M-55.36%
2021-07-29PurchaseRallybio Corporation
RLYB
10 percent owner
806,000
2.6995%
$13.00$10.48M-22.23%
2020-12-15Purchase4D Molecular Therapeutics, Inc.
FDMT
10 percent owner
2.2M
4.7935%
$23.00$50.6M-22.23%
2020-12-01SaleZentalis Pharmaceuticals, Inc.
ZNTL
10 percent owner
500,000
1.7356%
$50.50$25.25M+2.62%
2020-08-26PurchaseInhibrx, Inc.
INBX
10 percent owner
180,219
0.6943%
$18.92$3.41M+32.73%
2020-08-25PurchaseInhibrx, Inc.
INBX
10 percent owner
85,304
0.3175%
$19.36$1.65M+25.01%
2020-08-24PurchaseInhibrx, Inc.
INBX
10 percent owner
46,161
0.1645%
$19.43$897,001+19.04%
2020-04-07PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
10 percent owner
1.45M
3.199%
$18.00$26.1M+70.78%
2019-06-27PurchaseBridgeBio Pharma, Inc.
BBIO
10 percent owner
9.41M
30.5122%
$17.00$160M+6.17%
2015-02-08PurchaseEditas Medicine, Inc.
EDIT
2.04M
8.0725%
$16.04$32.73M
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.